Русский
Resolution of RSMSIM Expert council «State and prospects of pneumococcal vaccination in the Russian Federation»
DOI: https://dx.doi.org/10.18565/therapy.2023.4.130-136
Avdeev S.N., Bashankaev B.N., Briko N.I., Gorelov A.V., Zhdanov K.V., Kozlov R.S., Malyavin A.G., Martynov A.I., Polibin R.V., Sinopalnikov A.I., Tkacheva O.N., Fedenko A.A.
MARTYNOV A.I., MD, professor, academician of RAS, professor of the Department of hospital therapy No. 1 of A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia, president of Russian Scientific Medical Society of Internal Medicine (RSMSIM)
MALYAVIN A.G., MD, professor, professor of the Department of phthisiology and pulmonology of A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia, chief freelance pulmonologist of the Ministry of Healthcare of Russia in the Central Federal District, secretary general of RSMSIM
PARTICIPANTS:
AVDEEV S.N., MD, professor, academician of RAS, chief freelance pulmonologist of the Ministry of Health of Russia, head of the Department of pulmonology, director of the National Medical Research Center for Pulmonology of I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University), chief freelance pulmonologist of the Ministry of Healthcare of Russia
BASHANKAEV B.N., deputy chairman of the Health Protection Committee of the State Duma of the Russian Federation
BRIKO N.I., MD, professor, academician of RAS, head of the Department of epidemiology and evidence-based medicine, director of the Institute of Public Health named after F.F. Erisman of I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University)
GORELOV A.V., MD, professor, academician of RAS, deputy director of Central Research Institute of Epidemiology of Rospotrebnadzor, head of the Department of infectious diseases and epidemiology of A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia, president of National Association of Specialists in Infectious Diseases named after academician V.I. Pokrovsky
ZHDANOV K.V., MD, professor, corresponding member of RAS, chief infectionist of the Ministry of Defense of the Russian Federation, head of the Department and Clinic of infectious diseases (with a course in medical parasitology and tropical diseases) of S.M. Kirov Military Medical Academy Ministry of the Ministry of Defense of the Russian Federation
KOZLOV R.S., MD, professor, corresponding member of RAS, chief specialist in clinical microbiology and antimicrobial resistance of the Ministry of Healthcare of Russia, rector of Smolensk State Medical University of the Ministry of Healthcare of Russia, head of WHO Collaborating Center for Capacity Building in Surveillance and Antimicrobial Resistance Studies
POLIBIN R.V., PhD in Medical Sciences, chief freelance epidemiologist of the Ministry of Healthcare of Russia, deputy scientific director of the Institute of Public Health named after F.F. Erisman of I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University)
SINOPALNIKOV A.I., MD, professor, head of the Department of pulmonology of Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of Russia
TKACHEVA O.N., MD, professor, corresponding member of RAS, director of Russian Gerontological Scientific and Clinical Center, head of the Department of diseases of aging of N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia, chief freelance geriatrician of the Ministry of Healthcare of Russia, president of Russian Association of Gerontologists and Geriatricians
FEDENKO A.A., MD, head of the Department of drug treatment of tumors of Moscow Research Institute of Oncology named after P.A. Herzen – a branch of National Medical Research Center for Radiology of the Ministry of Healthcare of Russia
With the support of: Russian Scientific Medical Society of Internal Medicine (RSMSIM).
Literature
1. Указ «О национальных целях и стратегических задачах развития Российской Федерации на период до 2030 года». Доступ: http://www.consultant.ru/law/hotdocs/63714.html (дата обращения – 01.05.2023). [Decree «On national goals and strategic objectives of the development of the Russian Federation for the period up to 2030». URL: http://www.consultant.ru/law/hotdocs/63714.html (date of access – 01.05.2023) (In Russ.)]. 2. Стратегия развития иммунопрофилактики инфекционных болезней на период до 2035 года (с приложением) на 21 стр. Утв. распоряжением Правительства Российской Федерации от 18 сентября 2020 г. № 2390-р. [Strategy for the development of immunoprophylaxis of infectious diseases for the period up to 2035 (with annex) on 21 pages. Approved by order of the Government of the Russian Federation of September 18, 2020 No. 2390-r (In Russ.)]. 3. План мероприятий по реализации Стратегии развития иммунопрофилактики инфекционных болезней на период до 2035 года, утвержденный Правительством РФ от 29.03.21г. №774-р. [Action plan for the implementation of the Strategy for the development of immunoprophylaxis of infectious diseases for the period up to 2035, approved by the Government of the Russian Federation on 03/29/21. №774-r (In Russ.)]. 4. 23-valent pneumococcal polysaccharide vaccine. WHO position paper. Wkly Epidemiol Rec. 2008; 83(42): 373–84. 5. Данные Росстата, 2017–2018 гг. [Data of Federal State Statistics Service, 2017–2018 (In Russ.)]. 6. Руководство по клинической иммунологии в респираторной медицине (издание 2-е, дополненное). Под ред. М.П. Костинова, А.Г. Чучалина. М.: Группа МДВ. 2018; 304 с. [Guidelines for clinical immunology in respiratory medicine (2nd edition, revised). Ed. by Kostinova M.P., Chuchalin A.G. Moscow: MDV Group. 2018; 304 pp. (In Russ.)]. ISBN: 978-5-906748-08-9. EDN: XMJKMH. 7. Королева И.С. Информационно-аналитический обзор «Менингококковая инфекция и гнойные бактериальные менингиты в Российской Федерации 2017 год». М.: ЦНИИЭ Роспотребнадзора. 2017. [Koroleva I.S. Information and analytical review «Meningococcal infection and purulent bacterial meningitis in the Russian Federation 2017». Moscow: Central Research Institute of Epidemiology of Rospotrebnadzor. 2017 (In Russ.)]. 8. Данные статистических материалов ФГБУ «ЦНИИОИЗ» Минздрава России «Медико-демографические показатели Российской Федерации». Доступ: https://rosstat.gov.ru/storage/mediabank/BgjLrP31/demogr_01-06.pdf (дата обращения – 01.05.2023). [Data of statistical materials of the Central Research Institute of Organization and Informatization of Healthcare of the Ministry of Healthcare of Russia «Medical and demographic indicators of the Russian Federation». URL: https://rosstat.gov.ru/storage/mediabank/BgjLrP31/demogr_01-06.pdf (date of access – 01.05.2023) (In Russ.)]. 9. Kyaw M.H., Rose C.E. Jr., Fry A.M. et al. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis. 2005; 192(3) :377–86. https://dx.doi.org/10.1086/431521. 10. Тарасова А.А., Костинов М.П., Парамонова Ю.А. Подходы к вакцинопрофилактике респираторных инфекций у пациентов с сахарным диабетом в современной эпидемиологической ситуации. Сахарный диабет. 2019; 22(5): 473–480. [Tarasova A.A., Kostinov M.P., Paramonova Yu.A. Approaches to vaccine prophilaxis of respiratory infections in patients with diabetes mellitus in the modern epidemiological situation. Sakharnyy diabet = Diabetes Mellitus. 2019; 22(5): 473–480 (In Russ.)].https://dx.doi.org/10.14341/DM9820. EDN: DWGDFI. 11. Куликов П.В., Жоголев С.Д., Аминев Р.М. с соавт. Эпидемиологическая и этиологическая характеристика внебольничной пневмонии у военнослужащих по призыву в современный период. Сравнительная оценка эффективности пневмококковых вакцин. Журнал инфектологии. 2019; 11(2): 116–123. [Kulikov P.V., Zhogolev S.D., Aminev R.M. et al. Epidemiological and etiological characteristics of community-acquired pneumonia in conscripts in the modern period. comparative evaluation of the effectiveness of Pneumococcal vaccines. Zhurnal infektologii = Journal of Infectology. 2019; 11(2): 116–123 (In Russ.)].https://dx.doi.org/10.22625/2072-6732-2019-11-2-116-123. EDN: CQWBCG. 12. Metersky M.L., Masterton R.G., Lode H. et al. Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza. Int J Infect Dis. 2012; 16(5): e321–31. https://dx.doi.org/10.1016/j.ijid.2012.01.003. 13. Bonten M.J., Huijts S.M., Bolkenbaas M. et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N EnglJ Med. 2015; 372(12): 1114–25. https://dx.doi.org/10.1056/NEJMoa1408544. 14. Куркова А.А., Муравьев А.А., Козлов Р.С. Современное состояние антимикробной резистентности Streptococcus pneumoniae и специфической вакцинопрофилактики пневмококковой инфекции. Пульмонология. 2022; 3655. [Kurkova A.A., Muraviov A.A., Kozlov R.S. The current status of antimicrobial resistance of Streptococcus pneumonia and specific vaccine prevention of pneumococcal infection. Pulmonologiya = Pulmonology. 2022; 3655 (In Russ.)]. https://dx.doi.org/10.18093/0869-0189-2022-3655. 15. McLaughlin J.M., Jiang Q., Isturiz R.E. et al. Effectiveness of 13-valent pneumococcal conjugate vaccine against hospitalization for community-acquired pneumonia in older US adults: A test-negative design. Clin Infect Dis. 2018; 67(10): 1498–506.https://dx.doi.org/10.1093/cid/ciy312. 16. Игнатова Г.Л., Антонов В.Н. Анализ влияния вакцинации против пневмококковой инфекции на течение коморбидной патологии у пациентов с хронической обструктивной болезнью легких и хронической сердечной недостаточностью. Терапевтический архив. 2018; 90(8): 53–62. [Ignatova G.L., Antonov V.N. Efficiency of vaccine prophylaxis concentrated pneumococcal vaccine in patients with chronic obstructive lung disease and chronic heart failure. Terapevticheskiy arkhiv = Therapeutic Archive. 2018; 90(8): 53–62 (In Russ.)]. https://dx.doi.org/10.26442/terarkh201890853-62. EDN: XVYHGH. 17. Рудакова А.В., Брико Н.И., Лобзин Ю.В. с соавт. Вакцинация взрослых против пневмококковой инфекции в Российской Федерации: социальные 60 и фармакоэкономические аспекты. Журнал инфектологии. 2018; 10(3): 11–22. [Rudakova A.V., Briko N.I., Lobzin Yu.V. et al. Vaccination against Pneumococcal infections in Russian Federation: social and pharmacoeconomic aspects. Zhurnal infektologii = Journal of Infectology. 2018; 10(3): 11–22 (In Russ.)].https://dx.doi.org/10.22625/2072-6732-2018-10-3-11-22. EDN: YOQYXB. 18. Рудакова А.В., Брико Н.И., Лобзин Ю.В. с соавт. Фармакоэкономическая эффективность вакцинации против пневмококковой инфекции пациентов с сахарным диабетом. Эпидемиология и вакцинопрофилактика. 2022; 21(5): 78–88. [Rudakova A.V., Briko N.I., Lobzin Yu.V. et al. Cost-effectiveness of Pneumococcal vaccination among patients with diabetes mellitus. Epidemiologiya i vaktsinoprofilaktika = Epidemiology and Vaccination. 2022; 21(5): 78–88 (In Russ.)].https://dx.doi.org/10.31631/2073-3046-2022-21-5-78-88. EDN: CDSEYU. 19. Отчет о проведенном фармакоэкономическом исследовании на тему: «Фармакоэкономическая оценка вакцинации взрослых пациентов из групп риска пневмококковой конъюгированной 13-валентной вакциной (ПКВ13) в Российской Федерации». Оценка эффективности затрат и влияние на бюджет вакцинации с применением пневмококковых вакцин, включая ПКВ13, у взрослых пациентов с ХСН» 29.10.2021. ФГБОУ ВО «Санкт-Петербургский химико-фармацевтический университет» Минздрава России. [Report on the conducted pharmacoeconomic study on the topic: «Pharmacoeconomic evaluation of vaccination of adult patients at risk with pneumococcal conjugate 13-valent vaccine (PCV13) in the Russian Federation». Cost-effectiveness assessment and impact on the budget of vaccination with pneumococcal vaccines, including PCV13, in adult patients with CHF» 10/29/2021. Saint Petersburg Chemical and Pharmaceutical University of the Ministry of Healthcare of Russia (In Russ.)].
Similar Articles
